Yearly Archive for: "2018"

Shire/Allergan: too many wrinkles via @FT https://t.co/4t96S8HNlX — The Propell Group (@ThePropellGroup) April 20, 2018

Pace of drug price growth slows in US via @FT https://t.co/izGm6vnY8k — The Propell Group (@ThePropellGroup) April 20, 2018

P&G to buy Merck’s consumer health business for €3.4bn via @FT https://t.co/vNJV4ESEIj — The Propell Group (@ThePropellGroup) April 19, 2018

Shire rejects £42.4bn takeover from Japan’s Takeda via @FT https://t.co/lBqPkwvuaI — The Propell Group (@ThePropellGroup) April 19, 2018

Finance chiefs warn on Big Tech’s shift to banking https://t.co/fn7PMXly8U — The Propell Group (@ThePropellGroup) April 19, 2018

Bezos-backed cancer startup Grail seeks to raise $1b in HK offering: https://t.co/0Y0CDpvYhR — The Propell Group (@ThePropellGroup) April 19, 2018

Goldman Sachs asks in biotech research report: ‘Is curing patients a sustainable business model?’ https://t.co/7yb2bAqcLF — The Propell Group (@ThePropellGroup) April 19, 2018

“What’s in Store for 2018?” by @startuphealth https://t.co/qPc7Al2UfR — The Propell Group (@ThePropellGroup) April 19, 2018

https://t.co/4GLTp7NPEZ — The Propell Group (@ThePropellGroup) April 18, 2018

Int’l investors positive about China’s healthtech market: Ping An Insurance – Xinhua | https://t.co/sPbjwF2y4Y https://t.co/lTkNzT97Av — The Propell Group (@ThePropellGroup) [...]